3i Group Seeks to Cash In on Long-Standing India Investment
3i Group Plc is attempting to cash in on a long-standing investment in India. The company first sought to exit the investment nearly a decade ago, and is now making a renewed effort to monetize it.
The investment in question is in Sai Life Sciences, an Indian company in which 3i Group initially invested almost 15 years ago. In 2015, another investor, HBM Healthcare Investments, also put money into Sai Life Sciences. HBM later partially exited the investment through an IPO in 2024, selling some of its shares. Now, after a six-month lock-up period, HBM is planning to sell additional shares to further monetize its investment.
3i Group's attempt to exit its investment in Sai Life Sciences comes after several years of holding the stake. Meanwhile, HBM Healthcare Investments is also looking to fully realize its returns from the Indian company.
